Performing the transfer of a product or technology from a small-scale development process (or R&D process) to full-scale commercial manufacturing can prove challenging for...
Investing in People and Technology to Double Our Capacity Jubilant HollisterStier broke ground for our $285Mn Spokane facility expansion project on November 17, 2021. This...
02.09.2024, Spokane, WA – Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line...
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of...
On March 16 2023, Contract Pharma sat down and interviewed Chris Preti, when he was appointed as president of Jubilant HollisterStier. Chris Preti has more than 25 years of...
03.16.2022, Spokane, WA & Montreal, CA: Jubilant HollisterStier LLC, a leading pharmaceutical contract manufacturer and a subsidiary of Jubilant Pharma Limited, today...
On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug...
In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a...
